Month: June 2024

Appointment to EDF’s Board of Directors EDF’s Combined Annual General Meeting of June 11, 2024, on the recommendation of the Board of Directors meeting of June 10, 2024, appointed Mr. Bruno Even as a director to replace Mrs. Colette Lewiner. Mr Bruno Even is appointed for a term of three years, expiring at the close of the Ordinary General Meeting called to approve the financial statements for the year ending December 31, 2026. The Board is made up of 41.7% independent directors (excluding those representing employees), and 50% women. The Chairman and CEO and the members of the Board paid tribute to the commitment of Colette Lewiner, who has been with the company for many years, and thanked her for her decisive contributions. Biographies of all Board members are available at: https://www.edf.fr/en/the-edf-group/edf-at-a-glance/governance/board-of-directors. About...

Nokia CorporationStock Exchange Release11 June 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 11.06.2024 Espoo, Finland – On 11 June 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 408,211 3.56CEUX – –BATE – –AQEU – –TQEX – –Total 408,211 3.56* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Includes $36 million line of credit and potential $14 million private placementWARREN, N.J., June 11, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, following the recent elimination of $94.9 million in balance sheet liabilities, has entered into a definitive agreement for up to $50 million in financing. This formalizes the binding term sheet previously announced May 10, 2024. Combined with this financing, Tevogen’s efficient and innovative business model is expected to support research and development, particularly focusing on TVGN 489 the company’s initial product from its ExacTcell™ technology platform, and...

OAK RIDGE, N.C., June 11, 2024 (GLOBE NEWSWIRE) — Oak Ridge Financial Services, Inc. (“Oak Ridge”; the “Company”) (OTCPink: BKOR), the parent company of Bank of Oak Ridge (the “Bank”), was included in The American Banker’s Top 100 Publicly Traded Community Banks under $2 billion in assets. The ranking is based on data from year-end 2023 and uses the institutions’ three-year average return on average equity, or ROAE, to determine the ranking. Investors frequently use ROAE to analyze business performance and shareholder return. Oak Ridge’s three-year average ROAE for 2021-2023 was 13.25%. This year, American Banker and Capital Performance Group trimmed the list from the 200 top performers to 100 banks due to consolidation and the shrinking number of institutions in this asset class, better representing the top quartile of banks...

Boise, Idaho, June 11, 2024 (GLOBE NEWSWIRE) — Idaho Copper Corp. (OTC Pink: COPR) is pleased to announce that it has received results from scanning work performed by Veracio’s TruScan XRF (X-ray fluorescence) technology on the first six drillholes from the Company’s CuMo deposit in Idaho. The work involved the detailed scanning of cores at 1.5cm intervals, allowing the Company to examine the grades, composition, and distribution of copper and molybdenum contained in the deposit. The work is a follow up to the visual sorting analysis announced in June, 2022. The TruScan mobile scanning unit, which is about the size of a cargo van, contains sophisticated software and XRF scanning equipment that analyzes drill core to detect and measure copper and molybdenum grades. Each element present in a sample produces a set of characteristic...

Success of the “Ipsos Partnership 2024” operation Paris, 11 June 2024 – Ipsos Partners is an investment entity established in 2016 (see press release of 14 November 2016), dedicated to Ipsos’ executives and senior managers. As of December 31, 2023, Ipsos Partners held a 19% stake in DT & Partners, alongside Didier Truchot, Founder and Chairman of the Ipsos group, who owns 81%. DT & Partners is the Ipsos SA shareholder of reference, holding 11.2% of the capital and 19.0% of the voting rights as of December 31, 2023. Through the “Ipsos Partnership 2024” initiative, nearly 330 executives globally opted to invest in the structure, for a total of approximately 18 million euros. The capital raised will allow Ipsos Partners to buy back shares from managers who have left the company since 2018 and strengthen its...

HONG KONG, June 11, 2024 (GLOBE NEWSWIRE) — VS Media Holdings Limited (NASDAQ: VSME, the “Company”), a leader in managing a global network of digital creators, today announced that the Company is amending the effective date for its reverse stock split to Tuesday, June 18, 2024 to begin trading on a split-adjusted basis when the market opens, due to an unanticipated delay in obtaining necessary regulatory clearances. Previously, the Company had planned for its reverse split to become effective after the close of business on Monday, June 17, 2024, and had expected its Class A ordinary shares to begin trading on a split-adjusted basis when the market opened Monday, June 17, 2024. About VS Media VS Media Holdings Limited (NASDAQ: VSME) manages a network of leading digital creators across Asia Pacific that powers content-driven...

COSTA MESA, Calif., June 11, 2024 (GLOBE NEWSWIRE) — SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce a Research and Development agreement with Calypso Pharmaceuticals. The aim is to create a nano-emulsified topical formulation in collaboration with AVEINA, SIPP’s wellness-focused brand specializing in nanotechnology formulations, to target melanoma using Peptide P16. Peptide P16, a synthetic, cell-penetrating peptide derived from the melanoma suppressor P16, has demonstrated promising results in selectively killing melanoma cells while sparing normal cells. Utilizing Peptide P16 in nano emulsions for melanoma treatment offers a promising strategy to enhance apoptosis and effectively...